Racecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis. RACECADOTRIL is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications. Its therapeutic use is listed as antidiarrheals and gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Acetorphan, Hidrasec, Tiorfan and Tiorfix. Its PubChem CID is 107751.
Racecadotril
| CAS No | 81110-73-8 |
|---|---|
| Molecular Formula | C21H23NO4S |
| Molecular Weight | 385.5 g/mol |
| Synonyms | benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Racecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis. RACECADOTRIL is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications.
The listed CAS number is 81110-73-8.
The listed molecular formula is C21H23NO4S.
The listed molecular weight is 385.5 g/mol.
benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate.
The source lists Acetorphan, Hidrasec, Tiorfan and Tiorfix.